XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.4
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jan. 31, 2023
Oct. 31, 2022
Current assets:    
Cash and cash equivalents $ 1,154,873 $ 1,417,608
Short-term investments 147,050 147,913
Total cash, cash equivalents and short-term investments 1,301,923 1,565,521
Accounts receivable, net 1,035,323 796,091
Inventories 220,881 211,927
Prepaid and other current assets 470,272 439,130
Total current assets 3,028,399 3,012,669
Property and equipment, net 516,925 483,300
Operating lease right-of-use assets, net 586,892 559,090
Goodwill 3,864,833 3,842,234
Intangible assets, net 361,154 386,446
Deferred income taxes 719,082 670,653
Other long-term assets 488,339 463,695
Total assets 9,565,624 9,418,087
Current liabilities:    
Accounts payable and accrued liabilities 663,594 809,403
Operating lease liabilities 66,326 54,274
Deferred revenue 1,995,077 1,910,822
Total current liabilities 2,724,997 2,774,499
Long-term operating lease liabilities 603,538 581,273
Long-term deferred revenue 172,794 154,472
Long-term debt 20,569 20,824
Other long-term liabilities 364,975 327,829
Total liabilities 3,886,873 3,858,897
Redeemable non-controlling interest 36,049 38,664
Stockholders’ equity:    
Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding 0 0
Common stock, $0.01 par value: 400,000 shares authorized; 152,380 and 152,375 shares outstanding, respectively 1,524 1,524
Capital in excess of par value 1,292,900 1,487,126
Retained earnings 5,805,843 5,534,307
Treasury stock, at cost: 4,881 and 4,886 shares, respectively (1,321,180) (1,272,955)
Accumulated other comprehensive income (loss) (142,333) (234,277)
Total Synopsys stockholders’ equity 5,636,754 5,515,725
Non-controlling interest 5,948 4,801
Total stockholders’ equity 5,642,702 5,520,526
Total liabilities, redeemable non-controlling interest and stockholders’ equity $ 9,565,624 $ 9,418,087